Pfizer Inc. PFE, -0.31% and BioNTech SE BNTX, + 2.80% He said Monday night that they have started a late-stage clinical trial for one of their COVID-19 vaccine candidates, which involves 30,000 people worldwide. The start of the trial “is a great step forward in our progress towards the provision …
Read More »BioNTech COVID Vaccine Pfizer Enters Late-Stage Trial
